Ackermans & Van Haaren NV

ENXTBR:ACKB Lagerbericht

Marktkapitalisierung: €9.4b

Ackermans & Van Haaren Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Ackermans & Van Haaren wird ein jährliches Gewinn- und Umsatzwachstum von 3.1% bzw. 2.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 4.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.9% betragen.

Wichtige Informationen

3.1%

Wachstumsrate der Gewinne

4.28%

EPS-Wachstumsrate

Construction Gewinnwachstum11.0%
Wachstumsrate der Einnahmen2.2%
Zukünftige Eigenkapitalrendite9.85%
Analystenabdeckung

Low

Zuletzt aktualisiert12 Jun 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Narrativ-Update Jun 05

ACKB: Future Returns Will Reflect Raised Price Outlook And Updated Risk Profile

Analysts have lifted their price target for Ackermans & Van Haaren to €330 from €289, reflecting updated views on the stock's earnings profile and valuation assumptions. What's in the News The analyst price target for Ackermans & Van Haaren has been raised to €330 from €289, reflecting updated earnings assumptions and a revised valuation framework.
Narrativ-Update May 17

ACKB: Future Returns Will Reflect Updated Risk Profile And P E Assumptions

Analysts have raised their price target on Ackermans & Van Haaren to €330 from €289, citing updated views on the stock's risk profile, earnings outlook and P/E assumptions. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a €330 price target as better aligning the stock with their updated P/E assumptions, suggesting the current valuation may not fully reflect their earnings expectations.
Narrativ-Update Apr 23

ACKB: Future Returns Will Rely On P/E Support And Risk Assumptions

Analysts have lifted their price target on Ackermans & Van Haaren to €330 from €289, reflecting updated views on risk, growth and expected P/E that keep the stock aligned with their broader investment case. Analyst Commentary Bullish Takeaways Bullish analysts see the higher €330 price target as better aligned with their current assumptions on risk, growth and P/E, which they view as still coherent with the existing investment case.
Narrativ-Update Apr 08

ACKB: Future Returns Will Rely On P/E Support And Margin Resilience

Ackermans & Van Haaren's analyst price target has been revised to €330 from €289. Analysts point to updated assumptions on fair value, discount rate and future P/E as key drivers of the adjustment.
Narrativ-Update Mar 25

ACKB: Future Upside Will Depend On Sustained Margins And Earnings Power

Analysts have raised their price target on Ackermans & Van Haaren to €330 from €289, reflecting updated views on the stock's valuation drivers and risk profile. Analyst Commentary Bullish analysts are signaling a more constructive stance on Ackermans & Van Haaren, which is reflected in the higher price target of €330 compared with the previous €289 level.
Narrativ-Update Mar 09

ACKB: Fair Outlook Will Rely On Margins And Revenue Assumptions

The average analyst price target for Ackermans & Van Haaren has been adjusted from €277.71 to €291.86, with analysts citing updated assumptions around revenue growth, profit margins and forward P/E as key factors behind the change. Valuation Changes Fair Value: updated from €277.71 to €291.86, a modest upward adjustment in the modelled estimate.
Narrativ-Update Feb 23

ACKB: Fair Outlook Will Depend On Margins And Assumed Revenue Expansion

Analysts have lifted their price target on Ackermans & Van Haaren from €263.43 to €277.71, citing updated assumptions on revenue growth, profit margins and future P/E that point to a slightly higher fair value under a similar discount rate. Valuation Changes Fair Value: updated from €263.43 to €277.71, representing a modest uplift in the modelled estimate.
Narrativ-Update Feb 08

ACKB: Fair Outlook Will Rely On Stable Margins And Slight Multiple Adjustment

Analysts have kept their fair value estimate for Ackermans & Van Haaren steady at €263.43, with only marginal tweaks to assumptions such as the discount rate and future P/E. This reflects a broadly unchanged view of the company’s risk and earnings profile.
Analyseartikel Jan 28

There's Been No Shortage Of Growth Recently For Ackermans & Van Haaren's (EBR:ACKB) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
Narrativ-Update Jan 24

ACKB: Steady Outlook Will Rely On Stable Margins And Modest Multiple Shift

Ackermans & Van Haaren's analyst price target has been nudged higher, with fair value estimates moving from €254.83 to €263.43 as analysts factor in a slightly higher assumed future P/E and modest tweaks to the discount rate, long term margin, and growth inputs. Valuation Changes Fair Value: updated from €254.83 to €263.43, reflecting a modest uplift in the modelled estimate.
Narrativ-Update Jan 09

ACKB: Steady Fair Value And Minor Assumption Tweaks Will Shape Outlook

Analysts have kept their fair value estimate for Ackermans & Van Haaren steady at €254.83, indicating only minor adjustments in discount rate, revenue growth, profit margin and future P/E assumptions rather than a change in overall conviction. Valuation Changes Fair Value Estimate: Held steady at €254.83 per share, with no change between the previous and updated assessment.
Analyseartikel Jan 07

Ackermans & Van Haaren NV (EBR:ACKB) Shares Could Be 33% Below Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Ackermans & Van Haaren fair value estimate is €353 Ackermans...
Narrativ-Update Dec 14

ACKB: Modest Discount Rate Shift Will Support Future Earnings Strength

Analysts have modestly raised their price target on Ackermans & Van Haaren to €254.83, reflecting slightly lower discount rate assumptions while keeping long term growth and profitability expectations broadly unchanged. Valuation Changes Fair Value: Unchanged at approximately €254.83 per share, indicating no revision to the central valuation outcome.
Analyseartikel Dec 05

Ackermans & Van Haaren NV's (EBR:ACKB) Business Is Trailing The Market But Its Shares Aren't

There wouldn't be many who think Ackermans & Van Haaren NV's ( EBR:ACKB ) price-to-earnings (or "P/E") ratio of 13.9x...
Narrativ-Update Nov 29

ACKB: Future Earnings Strength Will Support Fair Value Estimate

Analysts have modestly adjusted their price target for Ackermans & Van Haaren, maintaining a fair value estimate of €254.83 as incremental shifts in discount rate and forward earnings expectations balance with softer revenue growth projections. Valuation Changes Fair Value Estimate remains unchanged at €254.83 per share.
Narrativ-Update Nov 15

ACKB: Net Profit Set To Climb At Least 15% In 2025

Analysts have raised their price target for Ackermans & Van Haaren from €253 to approximately €254.83. This change is attributed to a marginal increase in fair value, updated profit margin forecasts, and a slightly higher expected future price-to-earnings ratio.
Narrativ-Update Nov 01

ACKB: Net Profit Set To Increase At Least 15% In 2025 Guidance

Analysts have reaffirmed their price target for Ackermans & Van Haaren at €253, citing minimal adjustments in their key financial assumptions and market outlook. What's in the News Ackermans & Van Haaren has issued earnings guidance for 2025 and projects a net profit increase of at least 15% (Company Guidance).
Narrativ-Update Oct 18

Delen Private Bank And DEME Will Forge Future Investment Opportunities

Analysts have reiterated their price target for Ackermans & Van Haaren at €253.00. They cite largely unchanged revenue growth and profit margin forecasts as supporting factors for maintaining their fair value estimate.
Analyseartikel Oct 16

Ackermans & Van Haaren (EBR:ACKB) Is Doing The Right Things To Multiply Its Share Price

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
Narrativ-Update Oct 04

Delen Private Bank And DEME Will Forge Future Investment Opportunities

Analysts have raised their price target for Ackermans & Van Haaren from €244.67 to €253.00. This change reflects improved expectations for revenue growth and future valuation multiples, even though only minor adjustments were made to profitability forecasts.
Analyseartikel Sep 26

These 4 Measures Indicate That Ackermans & Van Haaren (EBR:ACKB) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Narrativ-Update Aug 30

Delen Private Bank And DEME Will Forge Future Investment Opportunities

The upward revision in Ackermans & Van Haaren’s price target is primarily driven by improved consensus forecasts for both revenue growth and net profit margin, raising the fair value estimate from €234.67 to €244.67. What's in the News Ackermans & Van Haaren expects net profit to increase by at least 15% for 2025.
Analyseartikel Aug 05

Ackermans & Van Haaren NV (EBR:ACKB) Investors Are Less Pessimistic Than Expected

With a median price-to-earnings (or "P/E") ratio of close to 15x in Belgium, you could be forgiven for feeling...
Analyseartikel Jun 28

The Return Trends At Ackermans & Van Haaren (EBR:ACKB) Look Promising

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
User avatar
Neues Narrativ Apr 06

Delen Private Bank And DEME Will Forge Future Investment Opportunities

Strong growth and collaboration in financial services suggest sustained revenue increases and enhanced banking operations.

Gewinn- und Umsatzwachstumsprognosen

ENXTBR:ACKB - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20286,4126739481,2862
12/31/20276,2036459041,2342
12/31/20266,2186207141,0333
12/31/20255,9625935361,005N/A
9/30/20256,0765637361,112N/A
6/30/20256,1915339371,218N/A
3/31/20256,1174961,0181,314N/A
12/31/20246,0434601,1001,410N/A
9/30/20245,8614448541,199N/A
6/30/20245,679429607988N/A
3/31/20245,450414396803N/A
12/31/20235,222399185619N/A
9/30/20234,959500150621N/A
6/30/20234,697601116622N/A
3/31/20234,549653159669N/A
12/31/20224,401706202717N/A
9/30/20224,446611286747N/A
6/30/20224,491517369777N/A
3/31/20224,394462416779N/A
12/31/20214,297407463782N/A
9/30/20214,181373495779N/A
6/30/20214,064339528776N/A
3/31/20213,987285439682N/A
12/31/20203,910230350587N/A
9/30/20203,889234202501N/A
6/30/20203,86923854414N/A
3/31/20204,07031768499N/A
12/31/20194,27039582585N/A
9/30/20194,334393N/A612N/A
6/30/20194,398391N/A640N/A
3/31/20194,435340N/A534N/A
12/31/20184,472290N/A428N/A
9/30/20184,402285N/A425N/A
6/30/20184,333281N/A422N/A
3/31/20184,149292N/A485N/A
12/31/20173,965303N/A549N/A
9/30/20173,938288N/A636N/A
6/30/20173,910273N/A723N/A
3/31/20173,785249N/A691N/A
12/31/20163,659224N/A658N/A
9/30/20163,639217N/A566N/A
6/30/20163,620210N/A474N/A
3/31/20163,819248N/A444N/A
12/31/20154,019285N/A414N/A
9/30/20154,041281N/AN/AN/A
6/30/20154,062277N/A607N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ACKBDas prognostizierte Gewinnwachstum (3.1% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: ACKBDie Erträge des Unternehmens (3.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Belgian (13.8% pro Jahr).

Hohe Wachstumserträge: ACKBDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: ACKBDie Einnahmen des Unternehmens (2.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Belgian (7.2% pro Jahr).

Hohe Wachstumseinnahmen: ACKBDie Einnahmen des Unternehmens (2.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ACKBDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.9%).


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/06/19 07:53
Aktienkurs zum Tagesende2026/06/19 00:00
Gewinne2025/12/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Ackermans & Van Haaren NV wird von 9 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Grégoire HermannBerenberg
Mourad LahmidiBNP Paribas
Joren Van AkenDegroof Petercam